BOMESI Foundation Opens Fifth Accelerator Cohort For Diverse-Owned Media Publishers And Creators 
Ynvisible Advances Commercial Program with Sapphiros, Announces CFO Appointment and Adoption of Semi-Annual Financial Reporting 
Airwheel SE3SX AI Wheel Luxury Suitcase Wins 2026 WGA for Smart Electric Riding Carry-On Hand Luggage 
Syntheia Signs Definitive Agreement for Sale of Call Center Assets and Announces Shares for Debt Transaction Solar Integrated Roofing Corp. Announces Solar Solution Initiative for Poultry Farms
SIRC Subsidiary USA Solar Networks Successful Beta Program to Provide Solar and Alternative Energy Solutions…
Commercial New Launch of Dosell Together with Hepro AS in Norway
STOCKHOLM, SWEDEN / ACCESSWIRE / November 24, 2021 / iZafe Group (STO:IZAFE-B) Hepro AS has…
GABY Inc. Reports Solid Q3 2021 Revenue of $9.5MM with Record Gross Profit Margin of 39%
Gross Profit Improved (pro forma, ex Sonoma Pacific Distribution Inc.) to $4.3MM Adjusted EBITDA* improved…
iZafe Group Invites Shareholders and Others to a Q&A Session Following The Publishing of The Third Quarter Report
STOCKHOLM, SWEDEN / ACCESSWIRE / November 24, 2021 / iZafe Group (STO:IZAFE-B) Stockholm, Sweden, iZafe…
u-blox AG: Easier Access to Market’s Best High Precision GNSS Positioning Performance
Two new GNSS correction service receivers and the firmware-upgraded ZED-F9P high precision GNSS receiver enable…
Blender Bites Receives Early Reorders from Canadian Club Stores, Indicating Strong Sales Velocity and Product Demand
VANCOUVER, BC / ACCESSWIRE / November 24, 2021 / Blender Bites Ltd. (the “Company“, “Blender…
Jericho Energy Ventures Teams up with Protium and Bruichladdich Distillery to Deploy Its Revolutionary Green Hydrogen Technology, Consortium Awarded USD$3.5 Million Funding from UK Government Green Distilleries Competition
Team of challenger brands spanning North America and the UK join forces to decarbonize Scottish…
Horizonte Minerals PLC Announces Result of Placing and Equity Fundraise
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM ANY PART…
Jan van Deursen Publishes a New Article
The entrepreneurial cell biologist authored a comprehensive piece outlining the results from a recent study…
New Reflection Token Project EVERDOT Launches with Ambitious Goals
JACKSONVILLE, FL / ACCESSWIRE / November 24, 2021 / EVERDOT, a new Polkadot reflection token…
Biovica Announces the Start of the TK IMPACT Trial at Washington University of St Louis
UPPSALA, SWEDEN / ACCESSWIRE / November 24, 2021 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica,…
Southern Energy Corp. Announces Closing of Equity Financing and Operational Update
Defined terms used in this announcement have the same meaning given to them as defined…
Emtelle Appoints David Parsons as Chief Commercial Officer
Hawick, Scotland, 24 November 2021 – Emtelle, the leading global manufacturer of blown fibre cable…
StaffCircle and IES Culture partner to drive ‘The Great Retention’
StaffCircle and IES Culture provide companies with strategy and infrastructure to create an irresistible company…
PHILOGEN ANNOUNCES NEW COLLABORATION WITH JANSSEN TO DISCOVER SMALL MOLECULE THERAPEUTICS
PHILOGEN ANNOUNCES NEW COLLABORATION WITH JANSSEN TO DISCOVER SMALL MOLECULE THERAPEUTICS Siena, Italy, November 24,…
DBV Technologies to Participate in an Upcoming Investor Conference
Montrouge, France, November 24, 2021 DBV Technologies to Participate in an Upcoming Investor Conference DBV…
OXURION to Present at the Ophthalmology Day at BTIG
Leuven, BELGIUM, Boston, MA, US – November 24, 2021 – 07.30 AM CET – Oxurion…
Santhera Provides Corporate Update and Calls Extraordinary General Meeting to Seek Approval for Further Financings
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, November 24, 2021 – Santhera…
Outlook Therapeutics Increases Previously Announced Bought Deal Offering of Common Stock to $50 Million
ISELIN, N.J., Nov. 23, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics”), a late…
HUTCHMED and AstraZeneca Initiate SACHI Phase III Trial of ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients in China After Progression on EGFR Inhibitor Therapy
— Follows important findings from the TATTON1 study of the combination in EGFR inhibitor refractory lung…